Gilead Sciences, Inc. (gild)
GILD News
Live headlines and press releases for Gilead Sciences, Inc. load in the terminal.
Company news & press releases is available in Vest Terminal for Professional and Enterprise subscribers.
Gilead Sciences, Inc. FAQ
What does Gilead Sciences, Inc. (GILD) do?
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor…
What is GILD's P/E ratio?
Gilead Sciences, Inc. has a trailing P/E of N/A× based on publicly available market data.
Does GILD pay a dividend?
Indicated dividend yield: 2.5%. Confirm ex-dates and payout history in Vest Terminal.
What sector is GILD in?
Gilead Sciences, Inc. is classified in Healthcare (Drug Manufacturers - General) on NMS.
What is GILD's market capitalization?
Approximate market cap: $162.47B.
What are the main risks for GILD?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of GILD?
Potential positives include revenue growth of 10.2% year-over-year, gross margin of 79.6% supports competitive unit economics.
Where can I get analyst estimates for GILD?
Consensus estimates, price targets, and detailed analyst data for Gilead Sciences, Inc. are available to Professional subscribers in Vest Terminal — not on this public summary page.